U.S. Life Sciences Stock News

NasdaqGM:BWMN
NasdaqGM:BWMNConstruction

3 Growth Companies To Watch With Insider Ownership Up To 19%

As February begins, the U.S. stock market has shown a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting investor optimism amid recent economic developments such as trade agreements and manufacturing growth. In this buoyant market environment, identifying growth companies with substantial insider ownership can be particularly compelling for investors seeking alignment between company leadership and shareholder interests.
NasdaqCM:RPID
NasdaqCM:RPIDLife Sciences

February 2026's Standout Penny Stocks To Consider

As February begins, the U.S. stock market is off to a strong start, with major indexes like the Dow Jones and S&P 500 posting significant gains. In such a buoyant market environment, investors often look beyond traditional stocks for opportunities that might offer substantial returns at lower entry points. Penny stocks, while an outdated term, still represent an intriguing investment area where smaller or newer companies can provide growth potential when underpinned by solid financials and...
NasdaqGS:XNET
NasdaqGS:XNETSoftware

US Market's Undiscovered Gems To Watch In February 2026

As February 2026 begins, the U.S. stock market is experiencing a strong upswing, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. This positive momentum comes amid broader economic developments such as trade deals and manufacturing growth, creating an environment ripe for identifying promising small-cap stocks that may have been overlooked. In this vibrant market landscape, a good stock often combines solid fundamentals with growth potential that...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) One Time EPS Surge To US$6.88 Challenges Cautious Profitability Narratives

Lyft FY 2025 earnings snapshot Lyft (LYFT) has capped FY 2025 with fourth quarter revenue of US$1.6 billion and basic EPS of US$6.88, against a trailing twelve month EPS of US$6.92 on revenue of US$6.3 billion that reflects very large year over year earnings growth and a sharply higher net profit margin. Over the last few quarters, the company has seen revenue move from US$1.45 billion in Q1 2025 to US$1.69 billion in Q3 2025, while basic EPS shifted from roughly breakeven at US$0.01 in Q1 to...
NYSE:SLVM
NYSE:SLVMForestry

Should Weaker Q4 2025 Profitability Require Action From Sylvamo (SLVM) Investors?

Sylvamo Corporation has reported past fourth-quarter 2025 results, with sales of US$890 million and net income of US$33 million, both below the prior year’s levels. The sharp drop in basic earnings per share from continuing operations to US$0.84 from US$1.98 highlights a meaningful squeeze on profitability. We will now examine how this weaker quarterly profitability shapes Sylvamo’s existing investment narrative built around efficiency gains and cash generation. AI is about to change...
NYSE:CIM
NYSE:CIMMortgage REITs

A Look At Chimera Investment (CIM) Valuation After Dividend Hike Acquisition And Q4 Profit Update

Dividend hike, acquisition, and Q4 profit put Chimera in focus Chimera Investment (CIM) is back on income investors radar after a 22% increase to its common dividend, the Home Express Mortgage acquisition, and a profitable fourth quarter update. See our latest analysis for Chimera Investment. Those updates have come alongside a 6.42% 1 day share price return and a 4.72% 7 day share price return, while the 1 year total shareholder return of 5.30% contrasts with weaker 3 and 5 year total...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

Azenta’s Space Trials Put Sample Tools And Valuation In New Focus

Azenta (NasdaqGS:AZTA) has entered a partnership with Frontier Space to bring its sample management technologies into space-based life sciences research. The collaboration includes testing Azenta’s FluidX consumables in microgravity and other extreme space conditions. This move introduces Azenta’s solutions to space research programs that rely on reliable sample handling and storage. For investors following life sciences tools and services, Azenta sits in the middle of sample management and...
NYSE:FLNG
NYSE:FLNGOil and Gas

FLEX LNG (FLNG) Margins Hold At 28.1% Reinforcing Profitability Narrative

FLEX LNG (NYSE:FLNG) has put up another steady quarter, reporting Q3 FY 2025 revenue of US$85.7 million and basic EPS of US$0.31. This is backed by trailing twelve month revenue of US$351.0 million and EPS of US$1.82. The company has seen revenue move between US$84.7 million and US$90.9 million per quarter since mid 2024, while quarterly EPS has ranged from US$0.31 to US$0.84 over the same period. These figures feed into a 28.1% net margin and 7.2% earnings growth over the last year. Overall,...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Incyte (INCY) Margin Jump To 25% Challenges Earnings Decline Narrative

Incyte (INCY) closed out FY 2025 with fourth quarter revenue of US$1.5 billion and basic EPS of US$1.52, alongside trailing 12 month revenue of US$5.1 billion and EPS of US$6.59 that sit against very large year over year earnings growth and a trailing net margin of 25%. Over the past year, revenue has moved from US$4.2 billion on a trailing basis to US$5.1 billion, while quarterly EPS has ranged from US$0.82 in Q1 2025 to US$2.17 in Q3 and US$1.52 in Q4. This gives investors a clearer read on...
NYSE:SITE
NYSE:SITETrade Distributors

SiteOne Landscape Supply (SITE) Q3 EPS Strength Tests High P/E And Thin Margin Narratives

SiteOne Landscape Supply (SITE) has just posted its latest FY 2025 numbers, with third quarter revenue of US$1.3b and EPS of US$1.32, anchored by trailing twelve month revenue of US$4.7b and EPS of US$3.11. The company reported revenue of US$1.2b in Q3 2024 and US$1.3b in Q3 2025, while quarterly EPS moved from US$0.98 to US$1.32 over the same period. This gives investors a clearer view of how the top line and per share earnings stack up against a net margin profile that remains relatively...
NYSE:MOH
NYSE:MOHHealthcare

Molina Healthcare (MOH) Q4 Loss And Margin Compression Challenge Bullish Earnings Narratives

Molina Healthcare (MOH) has just wrapped up FY 2025 with Q4 revenue of US$10.8b and a basic EPS loss of US$3.15, following earlier quarterly EPS of US$5.46, US$4.76 and US$1.50, while trailing 12 month EPS sits at US$8.92 on revenue of US$43.6b. Over the past six reported quarters, revenue has moved from US$9.8b in Q3 2024 to above US$10b per quarter in 2025, as quarterly EPS ranged from US$4.44 and US$5.66 in late 2024 to a loss in Q4 2025. This sets up a mixed picture on profitability. With...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Advanced Energy Industries AEIS Earnings Jump Tests Bullish Margin Narrative

Advanced Energy Industries (AEIS) has just closed out FY 2025 with fourth quarter revenue of US$489.4 million and basic EPS of US$1.40, with trailing twelve month revenue of US$1.8 billion and EPS of US$3.97 framing the full year picture. The company has seen quarterly revenue move from US$374.2 million in Q3 2024 to US$489.4 million in Q4 2025, while basic EPS has shifted from a loss of US$0.38 in Q3 2024 to US$1.40 in Q4 2025 and US$3.97 on a trailing basis, setting up a results season...
NYSE:NE
NYSE:NEEnergy Services

Is Noble (NE) Price Rally Outrunning Its Cash Flow And Earnings Valuation?

If you are wondering whether Noble's current share price lines up with its underlying worth, you are not alone. This article is here to unpack that question clearly. Noble's share price recently closed at US$44.06, with returns of 14.5% over 7 days, 47.3% over 30 days, 51.9% year to date, and 55.6% over 1 year, which has caught the attention of many investors thinking about growth potential and changing risk perceptions. Recent coverage of Noble has highlighted the stock's role in the energy...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

Pega (PEGA) Margin Surge To 22.5% Challenges Bearish Earnings Narratives

Pegasystems (PEGA) capped FY 2025 with fourth quarter revenue of US$504.3 million and basic EPS of US$1.38, alongside trailing twelve month revenue of US$1.75 billion and EPS of US$2.30, set against earnings growth of 296.7% over the past year. Over recent periods, the company has seen quarterly revenue move between US$325.1 million and US$504.3 million and basic EPS range from a loss of US$0.08 to a gain of US$1.38, while trailing net profit margin increased from 6.6% to 22.5%. For...
NYSE:DD
NYSE:DDChemicals

DuPont De Nemours (DD) One Off US$577 Million Loss Tests Bullish Margin Narrative

DuPont de Nemours (DD) has just laid out a choppy FY 2025 picture, with Q4 revenue of US$1.7 billion and a basic EPS loss of US$0.28, against a trailing twelve month EPS of US$1.73 built on revenue of US$12.8 billion and a reported 72.4% earnings growth over the last year. Over recent periods the company has seen revenue move from US$12.4 billion to US$12.8 billion on a trailing basis, while net margin has shifted from 3.8% to 5.7%. This sets up a story where stronger earnings growth, a one...